Quick Takeaways
- MORGAN STANLEY filed SCHEDULE 13G/A for Theratechnologies Inc. Common Shares (THTX).
- Disclosed ownership: 1.9%.
- Date of event: 30 Jun 2025.
MORGAN STANLEY - 30 Jun 2025 SCHEDULE 13G/A Report for Theratechnologies Inc. Common Shares (THTX)
- Filing Manager
- MORGAN STANLEY
- Reporting Manager
- Morgan Stanley
- Security
- Theratechnologies Inc. Common Shares
- Symbol
- THTX
- Shares outstanding
- 45,190,211 shares
- Disclosed Ownership
- 858,614 shares
- Ownership
- 1.9%
- Form type
- SCHEDULE 13G/A
- Filing time
- 05 Aug 2025, 15:08:52 UTC
- Date of event
- 30 Jun 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"MORGAN STANLEY disclosed 1.9% ownership in Theratechnologies Inc. Common Shares (THTX) on 30 Jun 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 05 Aug 2025, 15:08.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | 1.9% | 858,614 | 0 | 852,939 | Christopher O'Hara | Authorized Signatory, Morgan Stanley |